TNF and rheumatoid arthritis: TNF blockers also have been shown to induce antinuclear antibodies (ANA) and antibodies directed against double stranded (ds) DNA in autoimmune diseases, such as RA, spondyloarthritis (SpA) and systemic lupus erythematosus (SLE) [27,28].